Carestream Molecular Imaging, a division of Carestream Health, Inc., announced at the Joint Molecular Imaging Conference the introduction of KODAK X-SIGHT, new large stokes shift dyes for fluorescent in vivo imaging applications, which are reactive dyes designed to enable researchers and scientists to maximize the fluorescent signal while minimizing auto-fluorescence issues during in vivo imaging.

Philips showcased its complete preclinical product portfolio, including a new Preclinical Workspace, the MOSAIC HP preclinical PET system with a new software version, at the Joint AMI/SMI Molecular Imaging Conference, Sept. 7 to Sept. 11, in Providence, RI.

September 11, 2007 — STERIS Corp. announced that its Board of Directors has named Walter M. Rosebrough Jr., 53, president and chief executive officer, effective Oct. 1, 2007 and has elected Mr. Rosebrough to the Company’s Board effective that date.

As announced previously, Les C. Vinney, 58, STERIS’s president and chief executive officer since July 2000, will transition from this role on October 1, 2007 and thereafter continue to serve as a special advisor to the Company until his retirement in 2009.

September 11, 2007 - The color pink, specifically the pink ribbon, has come to symbolize efforts to find a cure for breast cancer. Could a dark pink dye hold the key to surviving breast cancer?

That is what researchers at Provectus Pharmaceuticals, are trying to determine with their new drug in development, Provecta, a key ingredient of which is Rose Bengal, a dark pink stain commonly used in eye drops to stain damaged eyes.

September 11, 2007 - Seventy-nine Michigan acute care hospitals received the Governor's Award for Improving Patient Safety and Quality of Care in the Hospital Setting.

September 11, 2007 - SmartDraw.com announced the launch of the SmartDraw Healthcare Edition 2008, the first program that automates the task of creating healthcare graphics including patient handouts, anatomical diagrams, treatment protocols, timelines, flowcharts, and much more.

September 11, 2007 — Researchers continue to search for a treatment to eradicate cancer, one of mankind's greatest afflictions and although a "cure" remains elusive, a vaccine to treat and prevent it may just be on the horizon.

Yvonne Paterson, Ph.D., a scientist who is also a breast cancer survivor, and her team of researchers appear to have taken a giant step forward by developing a series of cancer-fighting vaccines that appear to be able to stop and even reverse cancer growth.

September 11, 2007 - Pharmaceutical company Purdue Pharma L.P. has implemented a serialized product tracking (SPT) application to provide the key infrastructure needed to expand GEN 2 radio frequency identification (RFID) tagging of its OxyContin tablets.

September 11, 2007 —The BC-SeraPro blood serum test for detection of breast cancer is being developed by Power3, in conjunction with Mercy Hospital Women's Center.

The test analyzes biomarkers, or specific proteins, that indicate the difference between normal breast tissue, a benign breast disease, and a breast cancer. A recent study showed that the BC-SeraPro diagnostic test detected the disease accurately in 80 to 90 percent of the patients.

September 11, 2007 - The Certification Commission for Healthcare Information Technology (CCHIT) and the MITRE Corp. recently announced a collaborative relationship to begin building a testing resource to evaluate compliance of electronic health records (EHRs) and networks with certification criteria for interoperability.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now